Cargando…

Gut Microbiome Alteration after Reboxetine Administration in Type-1 Diabetic Rats

Antidepressants are drugs commonly used in clinical settings. However, there are very limited studies on the effects of these drugs on the gut microbiota. Herein, we evaluated the effect of reboxetine (RBX), a selective norepinephrine (noradrenaline) reuptake inhibitor (NRI), on gut microbiota in bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aydin, Sinem, Ozkul, Ceren, Yucel, Nazlı Turan, Karaca, Hulya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465486/ https://www.ncbi.nlm.nih.gov/pubmed/34576843 http://dx.doi.org/10.3390/microorganisms9091948

Ejemplares similares

Reboxetine-induced urinary hesitancy
por: Borade, Suresh, et al.
Publicado: (2005)

Reboxetine Improves Auditory Attention and Increases Norepinephrine Levels in the Auditory Cortex of Chronically Stressed Rats
por: Pérez-Valenzuela, Catherine, et al.
Publicado: (2016)

Effects of reboxetine and citalopram on appraisal of infant facial expressions and attentional biases
por: Stein, Alan, et al.
Publicado: (2012)

Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism
por: Kreiner, Grzegorz, et al.
Publicado: (2019)

Anti-Candidal Activity of Reboxetine and Sertraline Antidepressants: Effects on Pre-Formed Biofilms
por: Ahmed, Eman Ibrahim, et al.
Publicado: (2023)

The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
por: Aydin, Ömrüm, et al.
Publicado: (2018)

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation
por: Perger, Elisa, et al.
Publicado: (2023)

O001 Reboxetine reduces obstructive sleep apnea severity: a randomized trial
por: Altree, T, et al.
Publicado: (2021)

The selective norepinephrine reuptake inhibitor reboxetine promotes late-stage fracture healing in mice
por: Donat, Antonia, et al.
Publicado: (2023)

The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes
por: Zhao, Xue, et al.
Publicado: (2020)

Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome
por: Kato, Tamotsu, et al.
Publicado: (2018)

Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy
por: Das, Taraprasad, et al.
Publicado: (2021)

A comparison of the effects of reboxetine and placebo on reaction time in adults with Attention Deficit-Hyperactivity Disorder (ADHD)
por: Hashemian, F, et al.
Publicado: (2011)

Local and Global Resting State Activity in the Noradrenergic and Dopaminergic Pathway Modulated by Reboxetine and Amisulpride in Healthy Subjects
por: Metzger, Coraline D, et al.
Publicado: (2015)

Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study
por: Zheng, Guoxun, et al.
Publicado: (2016)

Effectiveness of Reboxetine in Treatment of Outpatient Children and Adolescents with Attention Deficit-Hyperactivity Disorder with Comorbid Anxiety Disorders
por: Riahi, Forough, et al.
Publicado: (2013)

Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats
por: Yu, Yiran, et al.
Publicado: (2018)

Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task
por: Liu, Yia-Ping, et al.
Publicado: (2009)

Erotic Stimulus Processing under Amisulpride and Reboxetine: A Placebo-Controlled fMRI Study in Healthy Subjects
por: Graf, Heiko, et al.
Publicado: (2015)

Alterations of the Gut Microbiome in Hypertension
por: Yan, Qiulong, et al.
Publicado: (2017)

Protective effect of royal jelly in 2,4,6 trinitrobenzene sulfonic acid-induced colitis in rats
por: Karaca, Turan, et al.
Publicado: (2015)

Alterations of the Gut Microbiome and Metabolome in Patients With Proliferative Diabetic Retinopathy
por: Ye, Panpan, et al.
Publicado: (2021)

Alterations in the gut microbiome and metabolome profiles of septic rats treated with aminophylline
por: Li, Yuanzhe, et al.
Publicado: (2022)

Crohn’s Disease Prediction Using Sequence Based Machine Learning Analysis of Human Microbiome
por: Unal, Metehan, et al.
Publicado: (2023)

Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
por: Davey, K J, et al.
Publicado: (2013)

Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas
por: Kwan, Suet-Ying, et al.
Publicado: (2022)

Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes
por: Takewaki, Fumie, et al.
Publicado: (2021)

The Altered Gut Microbiome and Necrotizing Enterocolitis
por: Torrazza, Roberto Murgas, et al.
Publicado: (2013)

Gut microbiome alterations in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2017)

Gut Microbiome Alterations in COVID-19
por: Zuo, Tao, et al.
Publicado: (2021)

Altered Gut Microbiome in Patients With Dermatomyositis
por: Bae, Sangmee Sharon, et al.
Publicado: (2022)

Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats
por: Yan, Zenghao, et al.
Publicado: (2020)

Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders
por: Karakan, Tarkan, et al.
Publicado: (2021)

Gut microbiome alterations in colitis rats after moxibustion at bilateral Tianshu acupoints
por: Qi, Qin, et al.
Publicado: (2022)

Alterations in the gut microbiome and metabolic profile in rats acclimated to high environmental temperature
por: Cao, Yang, et al.
Publicado: (2021)

Alteration of the Gut Microbiome in Normal and Overweight School Children from Selangor with Lactobacillus Fermented Milk Administration
por: Joseph, Narcisse, et al.
Publicado: (2020)

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial
por: Wiles, N. J., et al.
Publicado: (2014)

The gut microbiome in pancreatogenic diabetes differs from that of Type 1 and Type 2 diabetes
por: Talukdar, Rupjyoti, et al.
Publicado: (2021)

Gut microbiome in type 1 diabetes: A comprehensive review
por: Zheng, Peilin, et al.
Publicado: (2018)

Characteristics of the gut microbiome in patients with prediabetes and type 2 diabetes
por: Zhang, Zewen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8jhhiqld3gc2k2hrqk861mlb2u